Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1

Published:2019-09 Issue: Volume:859 Page:172541
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Xue Jing,Li Lei,Li Na,Li Feifei,Qin Xiaoyan,Li Tao,Liu Ming

Funder

Natural Science Foundation of China

Shandong Provincial Scientific and Technological Development Project of Medicine and Health

NHC Key Laboratory of Fertility Control Technology

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro;Alimova;Cell Cycle,2009

2. Linking type 2 diabetes and gynecological cancer: an introductory overview;Anastasi;Clin. Chem. Lab. Med.,2018

3. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy;Cantrell;Gynecol. Oncol.,2010

4. Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1;Cha;Mol. Cell,2018

5. Agents targeting ras signaling pathway;Dancey;Curr. Pharmaceut. Des.,2002

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment;Journal of Translational Medicine;2024-07-30

2. The ratio of PKM1/PKM2 is the key factor affecting the glucose metabolism and biological function of colorectal cancer cells;Translational Cancer Research;2024-07

3. Effects of Metformin on JNK Signaling Pathway and PD-L1 Expression in Triple Negative Breast Cancer;Cancer Management and Research;2024-04

4. Ginseng Glucosyl Oleanolate from Ginsenoside Ro, Exhibited Anti-Liver Cancer Activities via MAPKs and Gut Microbiota In Vitro/Vivo;Journal of Agricultural and Food Chemistry;2024-03-19

5. Recent advances and mechanisms of action of PD-L1 degraders as potential therapeutic agents;European Journal of Medicinal Chemistry;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3